ORGS - オ―ジェネシス (Orgenesis Inc.) オ―ジェネシス

 ORGSのチャート


 ORGSの企業情報

symbol ORGS
会社名 Orgenesis Inc (オ―ジェネシス)
分野(sector) Health Care   ヘルスケア
産業(industry) Major Pharmaceuticals  
業種 バイオテクノロジ―_メディカルリサ―チ   医療関連(Health Care)
概要 事業概要 Orgenesis Inc. is a regenerative therapy company. The Company operates through two segments: Contract Development and Manufacturing Organization (CDMO) and Cellular Therapy Business (CTB). The CDMO activity is operated by the Company's subsidiary MaSTherCell SA which specializes in cell therapy development for advanced medicinal products. MaSTherCell is providing two types of services to its customers: process and assay development services and good manufacturing practice (GMP) contract manufacturing services. The CTB activity is based on its technology that demonstrates the capacity to induce a shift in the developmental fate of cells from the liver and differentiating (converting) them into pancreatic beta cell-like insulin producing cells for patients with Type I Diabetes. It intends to advance a product that combines cell-based therapy and regenerative medicine Autologous Insulin Producing (AIP) cells into clinical development.   オ―ジェネシスは米国のバイオ医薬品企業。臨床段階で、糖尿病のトランス分化技術の開発・商業化に従事する。肝臓からの細胞発達の変化を促し、糖尿病1型患者の膵臓のベ―タ細胞のようなインスリン生産細胞に分化する技術に基づく細胞治療が含まれる。また、他の細胞治療に焦点を当てる事業も展開する。本社所在地はメリ―ランド州ジャ―マンタウン。   
本社所在地 20271 Goldenrod Lane Germantown MD 20876 USA
代表者氏名 Vered Caplan ヴェードキャプラン
代表者役職名 Chairman of the Board Chief Executive Officer President; Chief Executive Officer of Orgenesis Maryland Inc.
電話番号 +1 480-659-6404
設立年月日 39600
市場名 NASDAQ Small Cap
ipoyear ―年
従業員数 103人
url www.orgenesis.com
nasdaq_url https://www.nasdaq.com/symbol/orgs
adr_tso
EBITDA EBITDA(百万ドル) -5.41200
終値(lastsale) 6.63
時価総額(marketcap) 96594850.17
時価総額 時価総額(百万ドル) 96.85145
売上高 売上高(百万ドル) 16.23000
企業価値(EV) 企業価値(EV)(百万ドル) 82.92945
当期純利益 当期純利益(百万ドル) -14.15100
決算概要 決算概要 BRIEF: For the nine months ended 31 August 2018 Orgenesis Inc revenues increased 91% to $12.9M. Net loss applicable to common stockholders increased 26% to $13.3M. Revenues reflect CDMO segment increase from $4.7M to $23.5M CTB segment increase from $0K to $83K. Higher net loss reflects CTB segment loss increase from $6M to $14M. Basic Earnings per Share excluding Extraordinary Items increased from -$1.11 to -$1.07.

 ORGSのテクニカル分析


 ORGSのニュース

   Orgenesis Mobile Processing Units and Labs (OMPULs) to be Used for Point-of-Care Production and Commercialization of Cell and Gene Therapies in Collaboration with Dong-a University Hospital and Cure Therapeutics in South Korea  2021/03/08 12:30:00 GlobeNewswire
GERMANTOWN, Md., March 08, 2021 (GLOBE NEWSWIRE) -- Orgenesis Inc. (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a global biotech company working to…
   Orgenesis Second Quarter 2020 Revenue Increases 55% Reflecting Progress of POCare Platform  2020/08/07 07:30:00 Benzinga
Provides update on COVID-19 therapeutic programs Reports cash and cash equivalents of $97.5 million as of June 30, 2020 GERMANTOWN, Md., Aug. 07, 2020 …
   Orgenesis partners with Educell to conduct cell-based research programs (NASDAQ:ORGS)  2020/07/14 11:06:36 Seeking Alpha
Orgenesis (NASDAQ:ORGS) has collaborated with Educell Ltd., a European cell therapy company. Under the agreement, the parties plan to conduct one or more c
   ORGS, SLNO, CDTX, BLPH, ARCT added to Indexes (NASDAQ:ORGS)  2020/06/29 12:25:02 Seeking Alpha
Orgenesis (NASDAQ:ORGS) added to the Russell 3000 Index, effective after the market open June 29. Soleno Therapeutics (NASDAQ:SLNO) added to the Russell 30
   Orgenesis Second Quarter 2020 Revenue Increases 55% Reflecting Progress of POCare Platform  2020/08/07 07:30:00 Benzinga
Provides update on COVID-19 therapeutic programs Reports cash and cash equivalents of $97.5 million as of June 30, 2020 GERMANTOWN, Md., Aug. 07, 2020 …
   Orgenesis partners with Educell to conduct cell-based research programs (NASDAQ:ORGS)  2020/07/14 11:06:36 Seeking Alpha
Orgenesis (NASDAQ:ORGS) has collaborated with Educell Ltd., a European cell therapy company. Under the agreement, the parties plan to conduct one or more c
   ORGS, SLNO, CDTX, BLPH, ARCT added to Indexes (NASDAQ:ORGS)  2020/06/29 12:25:02 Seeking Alpha
Orgenesis (NASDAQ:ORGS) added to the Russell 3000 Index, effective after the market open June 29. Soleno Therapeutics (NASDAQ:SLNO) added to the Russell 30
   The Daily Biotech Pulse: EyePoint In-Licenses Eye Disorder Drug, BioMarin CFO Quits, Rockwell Medical To Offer Shares  2020/02/04 12:51:48 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs Feb. 3.) Acceleron Pharma Inc (NASDAQ: XLRN ) Aptose Biosciences Inc (NASDAQ: APTO ) Catalent Inc (NYSE: CTLT ) ( announced a deal to buy cell and gene therapy CDMO MasTherCell and forecast-beating second quarter results) ChemoCentryx Inc (NASDAQ: CCXI ) Clearside Biomedical Inc (NASDAQ: CLSD ) Fate Therapeutics Inc (NASDAQ: FATE ) ITAMAR MED LTD/S ADR (NASDAQ: ITMR ) Molecular Templates Inc (NASDAQ: MTEM ) Orgenesis Inc (NASDAQ: ORGS ) (announced sale of subsidiary MasTherCell to Catalent) Profound Medical Corp (NASDAQ: PROF ) Reata Pharmaceuticals Inc (NASDAQ: RETA ) Repligen Corporation (NASDAQ: RGEN ) Theravance Biopharma Inc (NASDAQ: TBPH ) Down In The Dumps (Biotech stocks that hit 52-week lows Feb. 3.) Alkermes Plc (NASDAQ: ALKS ) Allogene Therapeutics Inc (NASDAQ: ALLO ) Avanos Medical Inc (NYSE: AVNS ) BioLife Solutions Inc (NASDAQ: BLFS ) Blueprint Medicines Corp (NASDAQ: BPMC ) CASI Pharmaceuticals Inc (NASDAQ: CASI ) (moved along with China pharmaceutical stocks due to coronavirus) Endologix, Inc. (NASDAQ: ELGX ) Galectin Therapeutics Inc. (NASDAQ: GALT ) I-Mab (NASDAQ: IMAB ) (went public in mid-January) Intec Pharma Ltd (NASDAQ: NTEC ) TapImmune Inc. (NASDAQ: MRKR ) Omeros Corporation (NASDAQ: OMER ) REDHILL BIOPHAR/S ADR (NASDAQ: RDHL ) Salarius Pharmaceuticals Inc (NASDAQ: SLRX ) X4 …
   The Daily Biotech Pulse: Correvio Faces FDA Panel Rejection, Iterum's Antibiotic Trial Narrowly Misses Primary Endpoint  2019/12/11 12:21:31 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Dec. 10) Acceleron Pharma Inc (NASDAQ: XLRN ) Aimmune Therapeutics Inc (NASDAQ: AIMT ) argenx SE – ADR (NASDAQ: ARGX ) ArQule, Inc. (NASDAQ: ARQL )(agreed to be bought by Arvinas Inc (NASDAQ: ARVN ) Audentes Therapeutics Inc (NASDAQ: BOLD ) Aurinia Pharmaceuticals Inc (NASDAQ: AUPH ) Axsome Therapeutics Inc (NASDAQ: AXSM ) Avadel Pharmaceuticals PLC (NASDAQ: AVDL ) Bausch Health Companies Inc (NYSE: BHC ) BridgeBio Pharma Inc (NASDAQ: BBIO ) Bristol-Myers Squibb Co (NYSE: BMY )(reacted to ASH presentation) Deciphera Pharmaceuticals Inc (NASDAQ: DCPH ) Eidos Therapeutics Inc (NASDAQ: EIDX ) Flexion Therapeutics Inc (NASDAQ: FLXN ) Forty Seven Inc (NASDAQ: FTSV ) GALAPAGOS NV/S ADR (NASDAQ: GLPG ) GlaxoSmithKline plc (NYSE: GSK ) Global Blood Therapeutics Inc (NASDAQ: GBT ) Gossamer Bio Inc (NASDAQ: GOSS ) Immunomedics, Inc. (NASDAQ: IMMU ) Incyte Corporation (NASDAQ: INCY ) IVERIC bio Inc (NASDAQ: ISEE ) The Medicines Company (NASDAQ: MDCO ) Merck & Co.
   Orgenesis Second Quarter 2020 Revenue Increases 55% Reflecting Progress of POCare Platform  2020/08/07 07:30:00 Benzinga
Provides update on COVID-19 therapeutic programs Reports cash and cash equivalents of $97.5 million as of June 30, 2020 GERMANTOWN, Md., Aug. 07, 2020 …
   Orgenesis partners with Educell to conduct cell-based research programs (NASDAQ:ORGS)  2020/07/14 11:06:36 Seeking Alpha
Orgenesis (NASDAQ:ORGS) has collaborated with Educell Ltd., a European cell therapy company. Under the agreement, the parties plan to conduct one or more c
   ORGS, SLNO, CDTX, BLPH, ARCT added to Indexes (NASDAQ:ORGS)  2020/06/29 12:25:02 Seeking Alpha
Orgenesis (NASDAQ:ORGS) added to the Russell 3000 Index, effective after the market open June 29. Soleno Therapeutics (NASDAQ:SLNO) added to the Russell 30
   The Daily Biotech Pulse: EyePoint In-Licenses Eye Disorder Drug, BioMarin CFO Quits, Rockwell Medical To Offer Shares  2020/02/04 12:51:48 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs Feb. 3.) Acceleron Pharma Inc (NASDAQ: XLRN ) Aptose Biosciences Inc (NASDAQ: APTO ) Catalent Inc (NYSE: CTLT ) ( announced a deal to buy cell and gene therapy CDMO MasTherCell and forecast-beating second quarter results) ChemoCentryx Inc (NASDAQ: CCXI ) Clearside Biomedical Inc (NASDAQ: CLSD ) Fate Therapeutics Inc (NASDAQ: FATE ) ITAMAR MED LTD/S ADR (NASDAQ: ITMR ) Molecular Templates Inc (NASDAQ: MTEM ) Orgenesis Inc (NASDAQ: ORGS ) (announced sale of subsidiary MasTherCell to Catalent) Profound Medical Corp (NASDAQ: PROF ) Reata Pharmaceuticals Inc (NASDAQ: RETA ) Repligen Corporation (NASDAQ: RGEN ) Theravance Biopharma Inc (NASDAQ: TBPH ) Down In The Dumps (Biotech stocks that hit 52-week lows Feb. 3.) Alkermes Plc (NASDAQ: ALKS ) Allogene Therapeutics Inc (NASDAQ: ALLO ) Avanos Medical Inc (NYSE: AVNS ) BioLife Solutions Inc (NASDAQ: BLFS ) Blueprint Medicines Corp (NASDAQ: BPMC ) CASI Pharmaceuticals Inc (NASDAQ: CASI ) (moved along with China pharmaceutical stocks due to coronavirus) Endologix, Inc. (NASDAQ: ELGX ) Galectin Therapeutics Inc. (NASDAQ: GALT ) I-Mab (NASDAQ: IMAB ) (went public in mid-January) Intec Pharma Ltd (NASDAQ: NTEC ) TapImmune Inc. (NASDAQ: MRKR ) Omeros Corporation (NASDAQ: OMER ) REDHILL BIOPHAR/S ADR (NASDAQ: RDHL ) Salarius Pharmaceuticals Inc (NASDAQ: SLRX ) X4 …
   The Daily Biotech Pulse: Correvio Faces FDA Panel Rejection, Iterum's Antibiotic Trial Narrowly Misses Primary Endpoint  2019/12/11 12:21:31 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Dec. 10) Acceleron Pharma Inc (NASDAQ: XLRN ) Aimmune Therapeutics Inc (NASDAQ: AIMT ) argenx SE – ADR (NASDAQ: ARGX ) ArQule, Inc. (NASDAQ: ARQL )(agreed to be bought by Arvinas Inc (NASDAQ: ARVN ) Audentes Therapeutics Inc (NASDAQ: BOLD ) Aurinia Pharmaceuticals Inc (NASDAQ: AUPH ) Axsome Therapeutics Inc (NASDAQ: AXSM ) Avadel Pharmaceuticals PLC (NASDAQ: AVDL ) Bausch Health Companies Inc (NYSE: BHC ) BridgeBio Pharma Inc (NASDAQ: BBIO ) Bristol-Myers Squibb Co (NYSE: BMY )(reacted to ASH presentation) Deciphera Pharmaceuticals Inc (NASDAQ: DCPH ) Eidos Therapeutics Inc (NASDAQ: EIDX ) Flexion Therapeutics Inc (NASDAQ: FLXN ) Forty Seven Inc (NASDAQ: FTSV ) GALAPAGOS NV/S ADR (NASDAQ: GLPG ) GlaxoSmithKline plc (NYSE: GSK ) Global Blood Therapeutics Inc (NASDAQ: GBT ) Gossamer Bio Inc (NASDAQ: GOSS ) Immunomedics, Inc. (NASDAQ: IMMU ) Incyte Corporation (NASDAQ: INCY ) IVERIC bio Inc (NASDAQ: ISEE ) The Medicines Company (NASDAQ: MDCO ) Merck & Co.

 関連キーワード  (バイオテクノロジ―_メディカルリサ―チ 米国株 オ―ジェネシス ORGS Orgenesis Inc.)

 twitter  (公式ツイッターやCEOツイッターなど)